Universität Wien

323105 VU Innovation & Leadership in Preclinical Drug Development - MPS5 (2018S)

2.00 ECTS (1.00 SWS), SPL 32 - Pharmazie
Continuous assessment of course work

Details

Language: English

Lecturers

Classes

Tues & Wed. 06.03 & 07.03 17.30 – 19:00
Every Tues. 13.03, 10.04, 17.04, 24.04 17.30 – 19:30
Every Thurs. 08.03, 22.03, 12.04, 19.04, 26.04 17.30 – 19:30


Information

Aims, contents and method of the course

This course will introduce the concept of disruptive innovation, review exemplary innovators in health care and technology industries and examine advances in personalized medicine. Armed with this knowledge, students will identify a challenge in the context of preclinical drug develpment and interactively experience a creative process for designing an innovative solution. The challenge will provide a framework to explore the unique leadership competencies required to guide and shape creative teams, inspire the imagination needed to formulate and recognize a good idea, transform it into an innovation, and strategically present and communicate it effectively and persuasively. This course is in English and fulfills 2 ECTS.
1. What to expect: No single best strategy, or formulaic solutions! Although there is a great deal of research and literature covering the topic of innovation, there is no established protocol to guarantee success. In fact, the vast majority of innovation projects fail while some arise spontaneously. However, clear evidence from formal research supports the premise that implementation of creative environments and customized leadership that supports those environments are prerequisite for successful innovation within organizations.
2. Innovation awareness: This course will heighten your awareness of innovative people, firms, products and services. Why are they innovative and how did they change the way we do things. This knowledge is essential for understanding the unique leadership that is required to foster creative environments and be comfortable with creative processes for problem solving. Increasing your repertoire of knowledge will help you feel more confident with creative interactions, be better equipped to manage unpredictable challenges that arise during problem solving, and put effective strategies and behaviors into practice in order to achieve innovative outcomes. All of which can be applied to a variety of situations that you may face throughout your professional lives.
3. The Adult Learning Model: Adult learners take responsibility for their own learning and understand learning as a cooperative venture with other adults. They expect to be intellectually challenged, to discuss real experiences, to apply concepts and ideas directly to real situations. They make the commitment needed to achieve a beneficial learning experience. The classroom activities will be experiential and therefore require active participation and teamwork.
4. Class Session Format: Each session will involve a lecture, group exercises and/or team project work. Research and project work outside of class will be necessary in order to meet the milestones outlined for the course.
5. Laptops, tablets (ipads, etc), phones: Devices that will enable you to search the internet and gather information for your projects and class discussion are allowed and encouraged in this class. Please bring these items to class if you have them.

Assessment and permitted materials

1. Attendance & Participation: Participants are expected to attend all course sessions and actively participate in the course discussion as well as the innovation project. Course participation is a reflection of commitment to learning and the measure of it is at the discretion of the instructor. Measures of participation involve the following: course attendance (presence of both body and mind), preparation, insightful contributions, respect for other’s ideas, intellectual curiosity, demonstrated application of learning, a sense of humor and civility if stressful conditions arise.
2. Team oral presentation I. Team will present the challenge they identified and stakeholders involved. (4-5 slides) Powerpoint, Keynote or Openoffice formats (Team effort). Presentation must be given to the Professor by email before it is given orally. Content and requirements to be discussed.
3. Team oral presentation II: Covers the first conceptual design of a solution and a storyline (pitch). This is a draft presentation to prepare for the final presentation. Feedback given in class. Powerpoint, Keynote or Openoffice formats (Team effort). Content to be discussed. Presentation must be given to the Professor by email before it is given orally.
4.Required Final Assignment - Presentation III: Oral presentation (pitch) with a developed story line, the early prototype design for verification. Invited guests will give feedback on the prototype concept. A critical part of the prototyping process. Powerpoint, Keynote or OpenOffice formts (team effort). Presentation must be given to the Professor by email obefore it is given orally. Content and requirements to be discussed.

Minimum requirements and assessment criteria

Class attendance.
Active participation in class and with team.
Hand in deliverables outlined in class, e.g., Presentations, leadership self-assessment exercises, Team profiles.
Identify a challenge together with team and design an early stage solution guided by the course concepts.
Required Team Presentation I . First team oral presentation to present the challenge chosen and the key stakeholders involved. Openoffice, Powerpoint or Keynote presentation (Team effort). Presentation must be given to the Professor by email (PPT, KEY or OpenOffice format) before it is given orally. Content and requirements to be discussed.
iii. Required Presentation II . Team oral presentation on the first conceptual solution design based on the design process learned in class and a storyline. Powerpoint, Keynote, OpenOffice-presentation (Team effort). Content to be discussed. Presentation must be given to the Professor by email (PPT, KEY orOpen Office format) before it is given orally. Content and requirements to be discussed.
Final Presentation- Team Presentation of Pitch and early stage rough Prototype design.

Examination topics

iv. Required Final Assignment - Presentation III : Team Oral presentation with a developed story line (Pitch), and a prototype design (early stage mock-up of the design concept). Powerpoint, Keynote, OpenOffice presentation (team effort). Presentation must be given to the Professor by email (PPT, KEY or OpenOffice formats) before it is given orally. Content and requirements to be discussed.

Reading list

Recommended Reading (optional):
1. Ross, Alec. The Industries of the Future. Simon & Schuster, 2016.
2. Kelley, Tom. The Art of Innovation. New York: Doubleday, 2005.
3. Gallo, Carmine. The Innovation Secrets of Steve Jobs. New York: McGraw-Hill, 2011, 31.
4. Google’s Culture of Innovation, Innoblog, November 14, 2005, http://www.innosight.com/blog/index.php?/archives/36-Googles- Culture-of-Innovation.html.
5. “The Institutional Yes. An interview with Jeff Bezos,” Harvard Business Review, October 2007.
6. Keith Hammonds. “How Google Grows . . . and Grows . . . and Grows,” FastCompany.com. http://www.fastcompany.com/online/69/ google.html,
March 2003.
7. Vise, David & Mark Malseed. The Google Story. New York: Dela- corte Press, 2005, 256.
8. John Battelle. The Search: How Google and Its Rivals Rewrote the Rules of Business and Transformed Our Culture. New York: Penguin Group, 2005, 141.
9. Jonathan Ive, “Lessons On Designing Innovation,” interview, Radical Craft Conference, Art Center College of Design, Pasadena, CA, March 25, 2006.
10. Dyer, Jeff, Hal Gregersen & Clayton M. Christiansen. The Innovator’s DNA. Boston, MA: Harvard Business School Press, 2011.
11. Christiansen, Clayton M. & Michael Raynor. Innovator’s Solution. Boston, MA: Harvard Business School Press, 2003.
12. Christensen, Clayton M. The Innovator’s Dilemma: When New Technologies Cause Great Firms to Fail. Boston, MA, Harvard Business School Press, 1997.
13. Christensen, Clayton M. Meeting the Challenge of Disruptive Change. Harvard Bus. School Press, 1997.
14. “The Dream of Paul Janssen.” in Discover Janssen 7 July 201?
http://www.janssenbelgium.be/en/discover-janssen/the-dream-of-dr-paul-janssen
15. “Innovations in Pharmacy. Inspiring Inquiry and Improvement in Pharmacy Practice. University of Minnesota, USA. http://www.pharmacy.umn.edu/innovations/
16. Österreichische Apothekerkammer. http://www.apotheker.or.at/internet/oeak/NewsPresse.nsf/WebTeaser/NewsTeaser/
17. Österreichische Apothekerkammer. Links for download informational materials including videos.
http://www.apotheker.or.at/internet/oeak/downlink.nsf/WebDLKat!OpenView&Start=1&Count=100&Expand=16.15#16.15
18. Pfeiffer, KP et al., Country Brief: Austria. eHealth Strategies. Bonn/Brussels. Oct. 2010.
http://ehealth-strategies.eu/database/documents/Austria_CountryBrief_eHStrategies.pdf
19. Abou-Gharbia, M. & Childers, W.E. Discovery of Innovative Therapeutics: Today's Realities and Tomorrow's Vision. 1. Criticisms Faced by the Pharmaceutical Industry. J. Med. Chem. (2016):56, 5659.
20. Brown, Tim. Design Thinking. Harvard Business Review (2008), 84.
21. Mottl, J. Why today’s smartphones may be the only tech patients need. 13 December 2014. Available from: h p://www. ercemobilehealthcare.com/story/why-todays-smartphones- may-be-only-wearables-pa ents-need/2014-12-13.
22.Elvidge, S. Footfalls & Heartbeats: Smart knitted textiles for quanti ed self and patient monitoring Start-Up, 17 December 2013. Available from: h ps://www.pharmamedtechbi.com/ publica ons/start-up/18/11/foo alls-amp-heartbeats-ltd.
23. Szczerba, R.J. Why Mobile Health Technologies Haven’t Taken O (Yet). Forbes, 16 July 2014. Available from: h p://www.forbes. com/sites/robertszczerba/2014/07/16/why-mobile-health- technologies-havent-taken-o -yet/.

Association in the course directory

Last modified: Fr 31.08.2018 08:43